Global Epigenetic Market Size, Status and Forecast 2018-2025
SKU ID :QYR-12214946 | Published Date: 29-Aug-2018 | No. of pages: 91Description
TOC
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Epigenetic Market Size Growth Rate by Type (2018-2025)
1.4.2 DNA modifying Enzymes
1.4.3 RNA modifying Enzymes
1.4.4 Protein Modifying Enzymes
1.5 Market by Application
1.5.1 Global Epigenetic Market Share by Application (2017-2025)
1.5.2 Academic Research Institutes
1.5.3 Biotechnology Companies
1.5.4 Biopharmaceutical Companies
1.5.5 Diagnostic Companies
1.5.6 Contract Research Organizations
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Epigenetic Market Size
2.2 Epigenetic Growth Trends by Regions
2.2.1 Epigenetic Market Size by Regions (2017-2025)
2.2.2 Epigenetic Market Share by Regions (2017-2025)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases
3 Key Players
3.1 Epigenetic Revenue by Manufacturers (2017-2018)
3.2 Epigenetic Key Players Head office and Area Served
3.3 Key Players Epigenetic Product/Solution/Service
3.4 Date of Enter into Epigenetic Market
3.5 Key Players Epigenetic Funding/Investment Analysis
3.6 Global Key Players Epigenetic Valuation & Market Capitalization
3.7 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Epigenetic Market Size by Type (2017-2025)
4.2 Global Epigenetic Market Size by Application (2017-2025)
5 United States
5.1 United States Epigenetic Market Size (2017-2025)
5.2 Epigenetic Key Players in United States
5.3 United States Epigenetic Market Size by Type
5.4 United States Epigenetic Market Size by Application
6 Europe
6.1 Europe Epigenetic Market Size (2017-2025)
6.2 Epigenetic Key Players in Europe
6.3 Europe Epigenetic Market Size by Type
6.4 Europe Epigenetic Market Size by Application
7 China
7.1 China Epigenetic Market Size (2017-2025)
7.2 Epigenetic Key Players in China
7.3 China Epigenetic Market Size by Type
7.4 China Epigenetic Market Size by Application
8 Rest of World
8.1 Japan
8.1.1 Japan Epigenetic Market Analysis
8.1.2 Key Players in
8.2 Southeast Asia
8.2.1 Southeast Asia Epigenetic Market Analysis
8.2.2 Key Players in Southeast Asia
8.3 India
8.3.1 India Epigenetic Market Analysis
8.3.2 Key Players in India
9 International Players Profiles
9.1 Illumina
9.1.1 Illumina Company Details
9.1.2 Company Description and Business Overview
9.1.3 Epigenetic Introduction
9.1.4 Illumina Revenue in Epigenetic Business (2017-2018)
9.1.5 Illumina Recent Development
9.2 Qiagen
9.2.1 Qiagen Company Details
9.2.2 Company Description and Business Overview
9.2.3 Epigenetic Introduction
9.2.4 Qiagen Revenue in Epigenetic Business (2017-2018)
9.2.5 Qiagen Recent Development
9.3 Abcam
9.3.1 Abcam Company Details
9.3.2 Company Description and Business Overview
9.3.3 Epigenetic Introduction
9.3.4 Abcam Revenue in Epigenetic Business (2017-2018)
9.3.5 Abcam Recent Development
9.4 Merck & Co
9.4.1 Merck & Co Company Details
9.4.2 Company Description and Business Overview
9.4.3 Epigenetic Introduction
9.4.4 Merck & Co Revenue in Epigenetic Business (2017-2018)
9.4.5 Merck & Co Recent Development
9.5 Sigma-Aldrich
9.5.1 Sigma-Aldrich Company Details
9.5.2 Company Description and Business Overview
9.5.3 Epigenetic Introduction
9.5.4 Sigma-Aldrich Revenue in Epigenetic Business (2017-2018)
9.5.5 Sigma-Aldrich Recent Development
9.6 New England Biolabs
9.6.1 New England Biolabs Company Details
9.6.2 Company Description and Business Overview
9.6.3 Epigenetic Introduction
9.6.4 New England Biolabs Revenue in Epigenetic Business (2017-2018)
9.6.5 New England Biolabs Recent Development
9.7 Thermo Fisher Scientific
9.7.1 Thermo Fisher Scientific Company Details
9.7.2 Company Description and Business Overview
9.7.3 Epigenetic Introduction
9.7.4 Thermo Fisher Scientific Revenue in Epigenetic Business (2017-2018)
9.7.5 Thermo Fisher Scientific Recent Development
9.8 Diagenode
9.8.1 Diagenode Company Details
9.8.2 Company Description and Business Overview
9.8.3 Epigenetic Introduction
9.8.4 Diagenode Revenue in Epigenetic Business (2017-2018)
9.8.5 Diagenode Recent Development
9.9 Active Motif
9.9.1 Active Motif Company Details
9.9.2 Company Description and Business Overview
9.9.3 Epigenetic Introduction
9.9.4 Active Motif Revenue in Epigenetic Business (2017-2018)
9.9.5 Active Motif Recent Development
9.10 Roche Diagnostics
9.10.1 Roche Diagnostics Company Details
9.10.2 Company Description and Business Overview
9.10.3 Epigenetic Introduction
9.10.4 Roche Diagnostics Revenue in Epigenetic Business (2017-2018)
9.10.5 Roche Diagnostics Recent Development
9.11 Eisai
9.12 Novartis
10 Market Dynamics
10.1 Drivers
10.2 Opportunities
10.3 Challenges
10.4 Market Ecosystem
10.5 Market Value Chain Analysis
11 Key Findings in This Report
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Disclaimer
12.3 Author Details
Tables & Figures
List of Tables and Figures
Table Epigenetic Key Market Segments
Table Key Players Epigenetic Covered
Table Global Epigenetic Market Size Growth Rate by Type 2018-2025 (Million US$)
Figure Global Epigenetic Market Size Market Share by Type 2018-2025
Figure DNA modifying Enzymes Figures
Table Key Players of DNA modifying Enzymes
Figure RNA modifying Enzymes Figures
Table Key Players of RNA modifying Enzymes
Figure Protein Modifying Enzymes Figures
Table Key Players of Protein Modifying Enzymes
Table Global Epigenetic Market Size Growth by Application 2018-2025 (Million US$)
Figure Academic Research Institutes Case Studies
Figure Biotechnology Companies Case Studies
Figure Biopharmaceutical Companies Case Studies
Figure Diagnostic Companies Case Studies
Figure Contract Research Organizations Case Studies
Figure Epigenetic Report Years Considered
Table Global Epigenetic Market Size 2017-2025 (Million US$)
Figure Global Epigenetic Market Size and Growth Rate 2017-2025 (Million US$)
Table Global Epigenetic Market Size by Regions 2018-2025 (Million US$)
Table Global Epigenetic Market Size by Regions 2017-2025 (Million US$)
Table Global Epigenetic Market Share by Regions 2013-2018
Figure Global Epigenetic Market Share by Regions 2017-2025
Figure Global Epigenetic Market Share by Regions 2018-2025
Table Market Top Trends
Table Global Epigenetic Revenue by Manufacturers (2017-2018) (Million US$)
Table Global Epigenetic Market Share by Manufacturers (2017-2018)
Figure Global Epigenetic Market Share by Manufacturers in 2018
Table Global Key Players Epigenetic Funding/Investment Analysis (Million US$)
Table Global Key Players Epigenetic Valuation & Market Capitalization (Million US$)
Table Mergers & Acquisitions, Expansion Plans
Table Global Epigenetic Market Size by Type (2017-2025) (Million US$)
Table Global Epigenetic Market Share by Type (2017-2025)
Figure Global Epigenetic Market Size Share by Type (2017-2025)
Table Global Epigenetic Market Size by Application (2017-2025) (Million US$)
Table Global Epigenetic Market Size Share by Application (2017-2025)
Figure Global Epigenetic Market Size Market Share by Application (2017-2025)
Figure Global Epigenetic Revenue Market Share by Application in 2017
Figure United States Epigenetic Market Size 2017-2025 (Million US$)
Table United States Key Players Epigenetic Revenue (2017-2018) (Million US$)
Table United States Key Players Epigenetic Market Share (2017-2018)
Table United States Epigenetic Market Size by Type (2017-2025) (Million US$)
Table United States Epigenetic Market Share by Type (2017-2025)
Table United States Epigenetic Market Size by Application (2017-2025) (Million US$)
Table United States Epigenetic Market Share by Application (2017-2025)
Figure Europe Epigenetic Market Size 2017-2025 (Million US$)
Table Europe Key Players Epigenetic Revenue (2017-2018) (Million US$)
Table Europe Key Players Epigenetic Market Share (2017-2018)
Table Europe Epigenetic Market Size by Type (2017-2025) (Million US$)
Table Europe Epigenetic Market Share by Type (2017-2025)
Table Europe Epigenetic Market Size by Application (2017-2025) (Million US$)
Table Europe Epigenetic Market Share by Application (2017-2025)
Figure China Epigenetic Market Size 2017-2025 (Million US$)
Table China Key Players Epigenetic Revenue (2017-2018) (Million US$)
Table China Key Players Epigenetic Market Share (2017-2018)
Table China Epigenetic Market Size by Type (2017-2025) (Million US$)
Table China Epigenetic Market Share by Type (2017-2025)
Table China Epigenetic Market Size by Application (2017-2025) (Million US$)
Table China Epigenetic Market Share by Application (2017-2025)
Figure Market Size in Japan Epigenetic 2017-2025 (Million US$)
Figure Market Size in Southeast Asia Epigenetic 2017-2025 (Million US$)
Figure Market Size in India Epigenetic 2017-2025 (Million US$)
Table Illumina Company Details
Table Illumina Revenue in Epigenetic Business in 2017 and 2018
Table Illumina Recent Development
Table Qiagen Company Details
Table Qiagen Revenue in Epigenetic Business in 2017 and 2018
Table Qiagen Recent Development
Table Abcam Company Details
Table Abcam Revenue in Epigenetic Business in 2017 and 2018
Table Abcam Recent Development
Table Merck & Co Company Details
Table Merck & Co Revenue in Epigenetic Business in 2017 and 2018
Table Merck & Co Recent Development
Table Sigma-Aldrich Company Details
Table Sigma-Aldrich Revenue in Epigenetic Business in 2017 and 2018
Table Sigma-Aldrich Recent Development
Table New England Biolabs Company Details
Table New England Biolabs Revenue in Epigenetic Business in 2017 and 2018
Table New England Biolabs Recent Development
Table Thermo Fisher Scientific Company Details
Table Thermo Fisher Scientific Revenue in Epigenetic Business in 2017 and 2018
Table Thermo Fisher Scientific Recent Development
Table Diagenode Company Details
Table Diagenode Revenue in Epigenetic Business in 2017 and 2018
Table Diagenode Recent Development
Table Active Motif Company Details
Table Active Motif Revenue in Epigenetic Business in 2017 and 2018
Table Active Motif Recent Development
Table Roche Diagnostics Company Details
Table Roche Diagnostics Revenue in Epigenetic Business in 2017 and 2018
Table Roche Diagnostics Recent Development
Table Eisai Company Details
Table Novartis Company Details
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Companies
- PRICE
-
$3900$7800